Whitehawk Therapeutics develops antibody drug conjugates for cancer treatment, with its candidates in early clinical trials and based in New Jersey. It last closed at $3.08 on Nov 17, up 2.33% on the day.
Only 1 firm rated WHWK in the past 90 days, not enough for a consensus
Average 12-month target
$9.00
▲ 192.2% upside
Based on 1 analyst who set a price target on WHWK in the past 90 days. The average target is $9.00, with a high of $9.00 and a low of $9.00, compared with the last close of $3.08.
Low $9.00Avg $9.00High $9.00
Blue marker: last close $3.08
Highest target$9.00
Average target$9.00
Lowest target$9.00
Latest rating changes
StifelInitiated
Oct 1Buy$9
Leerink PartnersInitiated
Jul 13Buy$9
B. Riley SecuritiesInitiated
Jun 25Buy$10
CitizensInitiated
Apr 16Buy$8
Date
Firm
Action
Rating
Price target
Oct 1
Stifel
Initiated
Buy
$9
Jul 13
Leerink Partners
Initiated
Buy
$9
Jun 25
B. Riley Securities
Initiated
Buy
$10
Apr 16
Citizens
Initiated
Buy
$8
Loading…
Technical Analysis
WHWK · as of the Nov 17 close · updated after every close
Downtrend
The stock is 3% below its 20 day and 13% below its 50 day average. It is 25% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 44). The nearest support is the Pivot at $3.03, and the nearest resistance the Pivot R1 at $3.15.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 6.6%/day
Key levels
$5.5052 week high+78.6%
$3.89100 day average+26.3%
$3.86200 day average+25.3%
$3.4850 day average+13.0%
$3.37Swing high (Oct 22)+9.4%
$3.1820 day average+3.2%
$3.15Pivot R1+2.3%
$3.08Last close
$3.03Pivot−1.6%
$2.96Pivot S1−3.9%
$2.91Swing low (Nov 5)−5.5%
$1.9752 week low−36.0%
Indicators
RSI (14)
43.80
Middle of its range
Neutral
MACD
-0.11
Above its signal line
Bullish
Stochastic
23.3
Middle of its range
Neutral
ADX (14)
22.0
Weak trend
Williams %R
-71.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-105.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−0.7%
Change over 10 sessions
Bearish
ATR (14)
$0.20
Typical daily range, 6.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 16.3%/day
Key levels
$5.5052 week high+78.6%
$3.89100 day average+26.3%
$3.86200 day average+25.3%
$3.4850 day average+13.0%
$3.37Swing high (Oct 22)+9.4%
$3.1820 day average+3.2%
$3.15Pivot R1+2.3%
$3.08Last close
$3.03Pivot−1.6%
$2.96Pivot S1−3.9%
$2.91Swing low (Nov 5)−5.5%
$1.9752 week low−36.0%
Indicators
RSI (14)
39.79
Weak, oversold below 30
Neutral
MACD
-0.20
Below its signal line
Bearish
Stochastic
10.7
Near the bottom of its range
Oversold
ADX (14)
28.7
Trending down
Williams %R
-89.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-112.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−25.1%
Change over 10 sessions
Bearish
ATR (14)
$0.50
Typical daily range, 16.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for WHWK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how WHWK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow WHWK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How WHWK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WHWK is in one of them and how their past WHWK trades turned out.
Whitehawk Therapeutics is a drug developer based in Morristown, New Jersey, focused on cancer treatments. It is developing antibody drug conjugates, a type of treatment designed to deliver a cell-killing drug directly to tumor cells. Its product candidates are in early clinical trials for solid tumors such as lung, ovarian and endometrial cancers. The company's intended customers are cancer patients and the medical providers who treat them.